RxDoctor Payments DataLook up a doctor →

Suhail Dohad, MD

Interventional Cardiology · Beverly Hills, CANPI 1730151085

Payments from drug & device makers

$2,578,830in general payments, 2019–2025

Across 1,664 payments — averaging $1549.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cardiovascular Systems Inc.$702K
  • Penumbra, Inc.$699K
  • Boston Scientific$662K
  • Abbott$285K
  • Shockwave Medical, Inc$94K
  • M.a. Med Alliance S.A.$73K
  • plus $63K from 44 others
$1,684in research payments, 2019–2025

Across 1 payment — averaging $1684.44 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Philips North America LLC$2K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Cardiovascular Systems Inc.41$701,951
Penumbra, Inc.441$699,052
Boston Scientific442$662,040
Abbott216$285,307
Shockwave Medical, Inc60$94,173
M.a. Med Alliance S.A.4$72,887
Intact Vascular, Inc.2$12,718
Johnson & Johnson13$11,043
Philips North America LLC140$10,737
EKOS Corporation1$6,900
Abiomed59$5,199
Edwards Lifesciences54$3,898
Recor Medical Inc40$3,225
GE HealthCare2$2,373
Medtronic(2 entities)27$1,542
Teleflex LLC7$843
Heartflow, Inc.8$458
Amgen21$455
Cathworks, Inc.12$428
Surmodics, Inc.6$406
Cook Medical LLC6$319
Bard Peripheral Vascular, Inc.2$317
Inari Medical, Inc.3$313
Avinger Inc.5$235
Ablative Solutions, Inc.2$223
Neovasc Medical Inc1$210
Novartis7$171
Pfizer6$151
Asahi Intecc USA, Inc.1$146
Siemens Medical Solutions USA, Inc.1$135
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)3$102
Biotronik Inc.2$95
E.r. Squibb & Sons, L.L.C.5$86
Cordis US CORP.1$81
Imperative Care, Inc1$66
AstraZeneca3$61
Angiodynamics, Inc.2$61
Reflow Medical Inc2$60
Scpharmaceuticals Inc.2$49
Getinge USA Sales, LLC3$46
Kiniksa Pharmaceuticals International, PLC1$44
Bridgebio Pharma, Inc.1$33
Regeneron Healthcare Solutions, Inc.1$29
Itamar Medical Inc1$25
Novo Nordisk1$25
Sanofi-aventis U.S. LLC1$25
Sanofi1$22
Boehringer Ingelheim1$22
Actelion Pharmaceuticals US, Inc.1$20
Kestra Medical Technology Services, Inc.1$18

How this compares

$2,578,830 in reported general payments places this provider in the 95th percentile of 585 interventional cardiology providers in California.

See all interventional cardiology providers in California →

Medicare billing

Part B allowed, 2024
$519,649
Medicare patients
780
Services billed
2,584

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in Beverly Hills

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →